Although the original goal was to trigger an innate immune response against chicken T-cell lymphoma, the above data suggest that TLR3 agonists might have a direct pro-apoptotic effect on tumour cells. The gene discussed is TLR3; the disease is T-cell non-Hodgkin lymphoma.